Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial. Caspian J Intern Med 2022; 13 (2): 375-384
… This study revealed that curcumin improves remission through decreasing TNF-α level. Previous studies demonstrated that curcumin affected the transcription and angiogenic factors …..... Read More